nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B3—Docetaxel—melanoma	0.341	0.661	CbGbCtD
Olmesartan—ABCC2—Docetaxel—melanoma	0.175	0.339	CbGbCtD
Olmesartan—Telmisartan—PPARG—melanoma	0.00253	0.411	CrCbGaD
Olmesartan—Decreased appetite—Vemurafenib—melanoma	0.00118	0.00398	CcSEcCtD
Olmesartan—Bronchitis—Temozolomide—melanoma	0.00117	0.00395	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Vemurafenib—melanoma	0.00117	0.00395	CcSEcCtD
Olmesartan—Fatigue—Vemurafenib—melanoma	0.00117	0.00394	CcSEcCtD
Olmesartan—Constipation—Vemurafenib—melanoma	0.00116	0.00391	CcSEcCtD
Olmesartan—Pancytopenia—Temozolomide—melanoma	0.00116	0.0039	CcSEcCtD
Olmesartan—Lightheadedness—Docetaxel—melanoma	0.00116	0.0039	CcSEcCtD
Olmesartan—Neutropenia—Temozolomide—melanoma	0.00114	0.00384	CcSEcCtD
Olmesartan—Hyperglycaemia—Carmustine—melanoma	0.00114	0.00384	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Temozolomide—melanoma	0.00114	0.00382	CcSEcCtD
Olmesartan—Pneumonia—Carmustine—melanoma	0.00113	0.00382	CcSEcCtD
Olmesartan—Erectile dysfunction—Temozolomide—melanoma	0.00113	0.00379	CcSEcCtD
Olmesartan—Agranulocytosis—Dactinomycin—melanoma	0.00112	0.00378	CcSEcCtD
Olmesartan—Photosensitivity reaction—Temozolomide—melanoma	0.00112	0.00375	CcSEcCtD
Olmesartan—Renal failure—Carmustine—melanoma	0.00111	0.00373	CcSEcCtD
Olmesartan—Hyperglycaemia—Temozolomide—melanoma	0.0011	0.00371	CcSEcCtD
Olmesartan—Urinary tract infection—Carmustine—melanoma	0.0011	0.00369	CcSEcCtD
Olmesartan—Pneumonia—Temozolomide—melanoma	0.0011	0.00369	CcSEcCtD
Olmesartan—Infestation—Temozolomide—melanoma	0.00109	0.00367	CcSEcCtD
Olmesartan—Infestation NOS—Temozolomide—melanoma	0.00109	0.00367	CcSEcCtD
Olmesartan—Body temperature increased—Vemurafenib—melanoma	0.00107	0.00362	CcSEcCtD
Olmesartan—Pharyngitis—Dactinomycin—melanoma	0.00107	0.00361	CcSEcCtD
Olmesartan—Urinary tract infection—Temozolomide—melanoma	0.00106	0.00356	CcSEcCtD
Olmesartan—Alopecia—Bleomycin—melanoma	0.00102	0.00345	CcSEcCtD
Olmesartan—Sinusitis—Temozolomide—melanoma	0.00102	0.00344	CcSEcCtD
Olmesartan—Valsartan—ALB—melanoma	0.00101	0.165	CrCbGaD
Olmesartan—Oedema peripheral—Carmustine—melanoma	0.000997	0.00335	CcSEcCtD
Olmesartan—Connective tissue disorder—Carmustine—melanoma	0.000994	0.00335	CcSEcCtD
Olmesartan—Asthenia—Vemurafenib—melanoma	0.000975	0.00328	CcSEcCtD
Olmesartan—Pharyngitis—Temozolomide—melanoma	0.00097	0.00327	CcSEcCtD
Olmesartan—Urinary tract disorder—Temozolomide—melanoma	0.000966	0.00325	CcSEcCtD
Olmesartan—Oedema peripheral—Temozolomide—melanoma	0.000963	0.00324	CcSEcCtD
Olmesartan—Pruritus—Vemurafenib—melanoma	0.000962	0.00324	CcSEcCtD
Olmesartan—Connective tissue disorder—Temozolomide—melanoma	0.000961	0.00323	CcSEcCtD
Olmesartan—Lethargy—Docetaxel—melanoma	0.000959	0.00323	CcSEcCtD
Olmesartan—Urethral disorder—Temozolomide—melanoma	0.000958	0.00323	CcSEcCtD
Olmesartan—Alopecia—Dactinomycin—melanoma	0.000955	0.00322	CcSEcCtD
Olmesartan—Hyponatraemia—Docetaxel—melanoma	0.000944	0.00318	CcSEcCtD
Olmesartan—Pain in extremity—Docetaxel—melanoma	0.00094	0.00316	CcSEcCtD
Olmesartan—Ill-defined disorder—Bleomycin—melanoma	0.000936	0.00315	CcSEcCtD
Olmesartan—Anaemia—Bleomycin—melanoma	0.000933	0.00314	CcSEcCtD
Olmesartan—Diarrhoea—Vemurafenib—melanoma	0.00093	0.00313	CcSEcCtD
Olmesartan—Malaise—Bleomycin—melanoma	0.00091	0.00306	CcSEcCtD
Olmesartan—Telmisartan—ABCB1—melanoma	0.00091	0.148	CrCbGaD
Olmesartan—Arrhythmia—Carmustine—melanoma	0.000904	0.00304	CcSEcCtD
Olmesartan—Leukopenia—Bleomycin—melanoma	0.000903	0.00304	CcSEcCtD
Olmesartan—Dizziness—Vemurafenib—melanoma	0.000899	0.00303	CcSEcCtD
Olmesartan—Alopecia—Carmustine—melanoma	0.000894	0.00301	CcSEcCtD
Olmesartan—Angiopathy—Temozolomide—melanoma	0.000887	0.00299	CcSEcCtD
Olmesartan—Mental disorder—Carmustine—melanoma	0.000886	0.00298	CcSEcCtD
Olmesartan—Mediastinal disorder—Temozolomide—melanoma	0.000881	0.00297	CcSEcCtD
Olmesartan—Malnutrition—Carmustine—melanoma	0.000881	0.00296	CcSEcCtD
Olmesartan—Cough—Bleomycin—melanoma	0.000881	0.00296	CcSEcCtD
Olmesartan—Ill-defined disorder—Dactinomycin—melanoma	0.000873	0.00294	CcSEcCtD
Olmesartan—Anaemia—Dactinomycin—melanoma	0.00087	0.00293	CcSEcCtD
Olmesartan—Vomiting—Vemurafenib—melanoma	0.000864	0.00291	CcSEcCtD
Olmesartan—Alopecia—Temozolomide—melanoma	0.000864	0.00291	CcSEcCtD
Olmesartan—Chest pain—Bleomycin—melanoma	0.000859	0.00289	CcSEcCtD
Olmesartan—Myalgia—Bleomycin—melanoma	0.000859	0.00289	CcSEcCtD
Olmesartan—Orthostatic hypotension—Docetaxel—melanoma	0.000858	0.00289	CcSEcCtD
Olmesartan—Rash—Vemurafenib—melanoma	0.000857	0.00288	CcSEcCtD
Olmesartan—Mental disorder—Temozolomide—melanoma	0.000857	0.00288	CcSEcCtD
Olmesartan—Dermatitis—Vemurafenib—melanoma	0.000856	0.00288	CcSEcCtD
Olmesartan—Back pain—Carmustine—melanoma	0.000852	0.00287	CcSEcCtD
Olmesartan—Headache—Vemurafenib—melanoma	0.000852	0.00287	CcSEcCtD
Olmesartan—Malnutrition—Temozolomide—melanoma	0.000851	0.00286	CcSEcCtD
Olmesartan—Discomfort—Bleomycin—melanoma	0.000849	0.00286	CcSEcCtD
Olmesartan—Malaise—Dactinomycin—melanoma	0.000849	0.00286	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000846	0.00285	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000846	0.00285	CcSEcCtD
Olmesartan—Leukopenia—Dactinomycin—melanoma	0.000842	0.00284	CcSEcCtD
Olmesartan—Nasopharyngitis—Docetaxel—melanoma	0.000841	0.00283	CcSEcCtD
Olmesartan—Vision blurred—Carmustine—melanoma	0.00083	0.00279	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Docetaxel—melanoma	0.000829	0.00279	CcSEcCtD
Olmesartan—Oedema—Bleomycin—melanoma	0.000824	0.00277	CcSEcCtD
Olmesartan—Anaphylactic shock—Bleomycin—melanoma	0.000824	0.00277	CcSEcCtD
Olmesartan—Back pain—Temozolomide—melanoma	0.000823	0.00277	CcSEcCtD
Olmesartan—Infection—Bleomycin—melanoma	0.000818	0.00275	CcSEcCtD
Olmesartan—Anaemia—Carmustine—melanoma	0.000814	0.00274	CcSEcCtD
Olmesartan—Agitation—Carmustine—melanoma	0.000809	0.00272	CcSEcCtD
Olmesartan—Nausea—Vemurafenib—melanoma	0.000807	0.00272	CcSEcCtD
Olmesartan—Thrombocytopenia—Bleomycin—melanoma	0.000806	0.00271	CcSEcCtD
Olmesartan—Vision blurred—Temozolomide—melanoma	0.000802	0.0027	CcSEcCtD
Olmesartan—Myalgia—Dactinomycin—melanoma	0.000801	0.0027	CcSEcCtD
Olmesartan—Discomfort—Dactinomycin—melanoma	0.000792	0.00266	CcSEcCtD
Olmesartan—Angina pectoris—Docetaxel—melanoma	0.000791	0.00266	CcSEcCtD
Olmesartan—Ill-defined disorder—Temozolomide—melanoma	0.00079	0.00266	CcSEcCtD
Olmesartan—Leukopenia—Carmustine—melanoma	0.000788	0.00265	CcSEcCtD
Olmesartan—Anaemia—Temozolomide—melanoma	0.000787	0.00265	CcSEcCtD
Olmesartan—Anorexia—Bleomycin—melanoma	0.000785	0.00264	CcSEcCtD
Olmesartan—Agitation—Temozolomide—melanoma	0.000782	0.00263	CcSEcCtD
Olmesartan—Angioedema—Temozolomide—melanoma	0.000778	0.00262	CcSEcCtD
Olmesartan—Pancytopenia—Docetaxel—melanoma	0.000771	0.0026	CcSEcCtD
Olmesartan—Hypotension—Bleomycin—melanoma	0.00077	0.00259	CcSEcCtD
Olmesartan—Oedema—Dactinomycin—melanoma	0.000768	0.00259	CcSEcCtD
Olmesartan—Malaise—Temozolomide—melanoma	0.000768	0.00258	CcSEcCtD
Olmesartan—Vertigo—Temozolomide—melanoma	0.000765	0.00257	CcSEcCtD
Olmesartan—Infection—Dactinomycin—melanoma	0.000763	0.00257	CcSEcCtD
Olmesartan—Leukopenia—Temozolomide—melanoma	0.000762	0.00256	CcSEcCtD
Olmesartan—Neutropenia—Docetaxel—melanoma	0.00076	0.00256	CcSEcCtD
Olmesartan—Palpitations—Temozolomide—melanoma	0.000752	0.00253	CcSEcCtD
Olmesartan—Thrombocytopenia—Dactinomycin—melanoma	0.000752	0.00253	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Bleomycin—melanoma	0.00075	0.00253	CcSEcCtD
Olmesartan—Myalgia—Carmustine—melanoma	0.00075	0.00252	CcSEcCtD
Olmesartan—Chest pain—Carmustine—melanoma	0.00075	0.00252	CcSEcCtD
Olmesartan—Anxiety—Carmustine—melanoma	0.000747	0.00252	CcSEcCtD
Olmesartan—Cough—Temozolomide—melanoma	0.000743	0.0025	CcSEcCtD
Olmesartan—Candesartan—ABCB1—melanoma	0.000733	0.119	CrCbGaD
Olmesartan—Anorexia—Dactinomycin—melanoma	0.000732	0.00246	CcSEcCtD
Olmesartan—Pneumonia—Docetaxel—melanoma	0.000729	0.00245	CcSEcCtD
Olmesartan—Arthralgia—Temozolomide—melanoma	0.000725	0.00244	CcSEcCtD
Olmesartan—Myalgia—Temozolomide—melanoma	0.000725	0.00244	CcSEcCtD
Olmesartan—Infestation—Docetaxel—melanoma	0.000724	0.00244	CcSEcCtD
Olmesartan—Infestation NOS—Docetaxel—melanoma	0.000724	0.00244	CcSEcCtD
Olmesartan—Anxiety—Temozolomide—melanoma	0.000722	0.00243	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00072	0.00242	CcSEcCtD
Olmesartan—Oedema—Carmustine—melanoma	0.000719	0.00242	CcSEcCtD
Olmesartan—Discomfort—Temozolomide—melanoma	0.000716	0.00241	CcSEcCtD
Olmesartan—Decreased appetite—Bleomycin—melanoma	0.000716	0.00241	CcSEcCtD
Olmesartan—Infection—Carmustine—melanoma	0.000714	0.0024	CcSEcCtD
Olmesartan—Renal failure—Docetaxel—melanoma	0.000712	0.0024	CcSEcCtD
Olmesartan—Jaundice—Docetaxel—melanoma	0.000706	0.00238	CcSEcCtD
Olmesartan—Pain—Bleomycin—melanoma	0.000704	0.00237	CcSEcCtD
Olmesartan—Thrombocytopenia—Carmustine—melanoma	0.000704	0.00237	CcSEcCtD
Olmesartan—Tachycardia—Carmustine—melanoma	0.000702	0.00236	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Dactinomycin—melanoma	0.0007	0.00236	CcSEcCtD
Olmesartan—Anaphylactic shock—Temozolomide—melanoma	0.000695	0.00234	CcSEcCtD
Olmesartan—Oedema—Temozolomide—melanoma	0.000695	0.00234	CcSEcCtD
Olmesartan—Infection—Temozolomide—melanoma	0.00069	0.00232	CcSEcCtD
Olmesartan—Anorexia—Carmustine—melanoma	0.000685	0.00231	CcSEcCtD
Olmesartan—Nervous system disorder—Temozolomide—melanoma	0.000681	0.00229	CcSEcCtD
Olmesartan—Thrombocytopenia—Temozolomide—melanoma	0.00068	0.00229	CcSEcCtD
Olmesartan—Feeling abnormal—Bleomycin—melanoma	0.000679	0.00228	CcSEcCtD
Olmesartan—Agranulocytosis—Docetaxel—melanoma	0.000676	0.00228	CcSEcCtD
Olmesartan—Skin disorder—Temozolomide—melanoma	0.000675	0.00227	CcSEcCtD
Olmesartan—Hypotension—Carmustine—melanoma	0.000672	0.00226	CcSEcCtD
Olmesartan—Hyperhidrosis—Temozolomide—melanoma	0.000672	0.00226	CcSEcCtD
Olmesartan—Decreased appetite—Dactinomycin—melanoma	0.000668	0.00225	CcSEcCtD
Olmesartan—Fatigue—Dactinomycin—melanoma	0.000662	0.00223	CcSEcCtD
Olmesartan—Anorexia—Temozolomide—melanoma	0.000662	0.00223	CcSEcCtD
Olmesartan—Pain—Dactinomycin—melanoma	0.000657	0.00221	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Carmustine—melanoma	0.000655	0.0022	CcSEcCtD
Olmesartan—Urticaria—Bleomycin—melanoma	0.000654	0.0022	CcSEcCtD
Olmesartan—Rhinitis—Docetaxel—melanoma	0.000652	0.00219	CcSEcCtD
Olmesartan—Body temperature increased—Bleomycin—melanoma	0.000651	0.00219	CcSEcCtD
Olmesartan—Insomnia—Carmustine—melanoma	0.00065	0.00219	CcSEcCtD
Olmesartan—Pharyngitis—Docetaxel—melanoma	0.000645	0.00217	CcSEcCtD
Olmesartan—Urinary tract disorder—Docetaxel—melanoma	0.000642	0.00216	CcSEcCtD
Olmesartan—Oedema peripheral—Docetaxel—melanoma	0.000641	0.00216	CcSEcCtD
Olmesartan—Connective tissue disorder—Docetaxel—melanoma	0.000639	0.00215	CcSEcCtD
Olmesartan—Urethral disorder—Docetaxel—melanoma	0.000637	0.00215	CcSEcCtD
Olmesartan—Feeling abnormal—Dactinomycin—melanoma	0.000633	0.00213	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Temozolomide—melanoma	0.000633	0.00213	CcSEcCtD
Olmesartan—Insomnia—Temozolomide—melanoma	0.000628	0.00211	CcSEcCtD
Olmesartan—Gastrointestinal pain—Dactinomycin—melanoma	0.000628	0.00211	CcSEcCtD
Olmesartan—Decreased appetite—Carmustine—melanoma	0.000625	0.0021	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Carmustine—melanoma	0.000621	0.00209	CcSEcCtD
Olmesartan—Constipation—Carmustine—melanoma	0.000615	0.00207	CcSEcCtD
Olmesartan—Pain—Carmustine—melanoma	0.000615	0.00207	CcSEcCtD
Olmesartan—Dyspepsia—Temozolomide—melanoma	0.000611	0.00206	CcSEcCtD
Olmesartan—Abdominal pain—Dactinomycin—melanoma	0.000607	0.00204	CcSEcCtD
Olmesartan—Body temperature increased—Dactinomycin—melanoma	0.000607	0.00204	CcSEcCtD
Olmesartan—Decreased appetite—Temozolomide—melanoma	0.000604	0.00203	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Temozolomide—melanoma	0.0006	0.00202	CcSEcCtD
Olmesartan—Fatigue—Temozolomide—melanoma	0.000599	0.00202	CcSEcCtD
Olmesartan—Constipation—Temozolomide—melanoma	0.000594	0.002	CcSEcCtD
Olmesartan—Pain—Temozolomide—melanoma	0.000594	0.002	CcSEcCtD
Olmesartan—Feeling abnormal—Carmustine—melanoma	0.000592	0.00199	CcSEcCtD
Olmesartan—Asthenia—Bleomycin—melanoma	0.000591	0.00199	CcSEcCtD
Olmesartan—Angiopathy—Docetaxel—melanoma	0.00059	0.00199	CcSEcCtD
Olmesartan—Gastrointestinal pain—Carmustine—melanoma	0.000588	0.00198	CcSEcCtD
Olmesartan—Mediastinal disorder—Docetaxel—melanoma	0.000586	0.00197	CcSEcCtD
Olmesartan—Pruritus—Bleomycin—melanoma	0.000583	0.00196	CcSEcCtD
Olmesartan—Arrhythmia—Docetaxel—melanoma	0.000581	0.00196	CcSEcCtD
Olmesartan—Alopecia—Docetaxel—melanoma	0.000575	0.00193	CcSEcCtD
Olmesartan—Feeling abnormal—Temozolomide—melanoma	0.000572	0.00193	CcSEcCtD
Olmesartan—Mental disorder—Docetaxel—melanoma	0.00057	0.00192	CcSEcCtD
Olmesartan—Abdominal pain—Carmustine—melanoma	0.000568	0.00191	CcSEcCtD
Olmesartan—Body temperature increased—Carmustine—melanoma	0.000568	0.00191	CcSEcCtD
Olmesartan—Gastrointestinal pain—Temozolomide—melanoma	0.000568	0.00191	CcSEcCtD
Olmesartan—Malnutrition—Docetaxel—melanoma	0.000566	0.00191	CcSEcCtD
Olmesartan—Urticaria—Temozolomide—melanoma	0.000552	0.00186	CcSEcCtD
Olmesartan—Asthenia—Dactinomycin—melanoma	0.000551	0.00185	CcSEcCtD
Olmesartan—Body temperature increased—Temozolomide—melanoma	0.000549	0.00185	CcSEcCtD
Olmesartan—Abdominal pain—Temozolomide—melanoma	0.000549	0.00185	CcSEcCtD
Olmesartan—Back pain—Docetaxel—melanoma	0.000548	0.00184	CcSEcCtD
Olmesartan—Muscle spasms—Docetaxel—melanoma	0.000544	0.00183	CcSEcCtD
Olmesartan—Diarrhoea—Dactinomycin—melanoma	0.000526	0.00177	CcSEcCtD
Olmesartan—Vomiting—Bleomycin—melanoma	0.000524	0.00176	CcSEcCtD
Olmesartan—Anaemia—Docetaxel—melanoma	0.000523	0.00176	CcSEcCtD
Olmesartan—Rash—Bleomycin—melanoma	0.000519	0.00175	CcSEcCtD
Olmesartan—Dermatitis—Bleomycin—melanoma	0.000519	0.00175	CcSEcCtD
Olmesartan—Asthenia—Carmustine—melanoma	0.000516	0.00174	CcSEcCtD
Olmesartan—Syncope—Docetaxel—melanoma	0.000508	0.00171	CcSEcCtD
Olmesartan—Leukopenia—Docetaxel—melanoma	0.000507	0.00171	CcSEcCtD
Olmesartan—Palpitations—Docetaxel—melanoma	0.0005	0.00168	CcSEcCtD
Olmesartan—Asthenia—Temozolomide—melanoma	0.000498	0.00168	CcSEcCtD
Olmesartan—Loss of consciousness—Docetaxel—melanoma	0.000498	0.00167	CcSEcCtD
Olmesartan—Losartan—ALB—melanoma	0.000495	0.0804	CrCbGaD
Olmesartan—Cough—Docetaxel—melanoma	0.000494	0.00166	CcSEcCtD
Olmesartan—Diarrhoea—Carmustine—melanoma	0.000492	0.00166	CcSEcCtD
Olmesartan—Pruritus—Temozolomide—melanoma	0.000491	0.00165	CcSEcCtD
Olmesartan—Nausea—Bleomycin—melanoma	0.000489	0.00165	CcSEcCtD
Olmesartan—Vomiting—Dactinomycin—melanoma	0.000488	0.00164	CcSEcCtD
Olmesartan—Rash—Dactinomycin—melanoma	0.000484	0.00163	CcSEcCtD
Olmesartan—Arthralgia—Docetaxel—melanoma	0.000482	0.00162	CcSEcCtD
Olmesartan—Chest pain—Docetaxel—melanoma	0.000482	0.00162	CcSEcCtD
Olmesartan—Myalgia—Docetaxel—melanoma	0.000482	0.00162	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000479	0.00161	CcSEcCtD
Olmesartan—Dizziness—Carmustine—melanoma	0.000475	0.0016	CcSEcCtD
Olmesartan—Diarrhoea—Temozolomide—melanoma	0.000475	0.0016	CcSEcCtD
Olmesartan—Losartan—ABCB1—melanoma	0.000473	0.0767	CrCbGaD
Olmesartan—Oedema—Docetaxel—melanoma	0.000462	0.00155	CcSEcCtD
Olmesartan—Anaphylactic shock—Docetaxel—melanoma	0.000462	0.00155	CcSEcCtD
Olmesartan—Dizziness—Temozolomide—melanoma	0.000459	0.00155	CcSEcCtD
Olmesartan—Infection—Docetaxel—melanoma	0.000459	0.00154	CcSEcCtD
Olmesartan—Vomiting—Carmustine—melanoma	0.000457	0.00154	CcSEcCtD
Olmesartan—Nausea—Dactinomycin—melanoma	0.000456	0.00154	CcSEcCtD
Olmesartan—Shock—Docetaxel—melanoma	0.000455	0.00153	CcSEcCtD
Olmesartan—Rash—Carmustine—melanoma	0.000453	0.00153	CcSEcCtD
Olmesartan—Nervous system disorder—Docetaxel—melanoma	0.000453	0.00152	CcSEcCtD
Olmesartan—Dermatitis—Carmustine—melanoma	0.000453	0.00152	CcSEcCtD
Olmesartan—Thrombocytopenia—Docetaxel—melanoma	0.000452	0.00152	CcSEcCtD
Olmesartan—Tachycardia—Docetaxel—melanoma	0.000451	0.00152	CcSEcCtD
Olmesartan—Headache—Carmustine—melanoma	0.00045	0.00152	CcSEcCtD
Olmesartan—Skin disorder—Docetaxel—melanoma	0.000449	0.00151	CcSEcCtD
Olmesartan—Vomiting—Temozolomide—melanoma	0.000442	0.00149	CcSEcCtD
Olmesartan—Anorexia—Docetaxel—melanoma	0.00044	0.00148	CcSEcCtD
Olmesartan—Rash—Temozolomide—melanoma	0.000438	0.00147	CcSEcCtD
Olmesartan—Dermatitis—Temozolomide—melanoma	0.000438	0.00147	CcSEcCtD
Olmesartan—Headache—Temozolomide—melanoma	0.000435	0.00146	CcSEcCtD
Olmesartan—Hypotension—Docetaxel—melanoma	0.000432	0.00145	CcSEcCtD
Olmesartan—Nausea—Carmustine—melanoma	0.000427	0.00144	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Docetaxel—melanoma	0.000421	0.00142	CcSEcCtD
Olmesartan—Insomnia—Docetaxel—melanoma	0.000418	0.00141	CcSEcCtD
Olmesartan—Nausea—Temozolomide—melanoma	0.000413	0.00139	CcSEcCtD
Olmesartan—Dyspepsia—Docetaxel—melanoma	0.000407	0.00137	CcSEcCtD
Olmesartan—Decreased appetite—Docetaxel—melanoma	0.000402	0.00135	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Docetaxel—melanoma	0.000399	0.00134	CcSEcCtD
Olmesartan—Fatigue—Docetaxel—melanoma	0.000398	0.00134	CcSEcCtD
Olmesartan—Pain—Docetaxel—melanoma	0.000395	0.00133	CcSEcCtD
Olmesartan—Constipation—Docetaxel—melanoma	0.000395	0.00133	CcSEcCtD
Olmesartan—Feeling abnormal—Docetaxel—melanoma	0.000381	0.00128	CcSEcCtD
Olmesartan—Gastrointestinal pain—Docetaxel—melanoma	0.000378	0.00127	CcSEcCtD
Olmesartan—Abdominal pain—Docetaxel—melanoma	0.000365	0.00123	CcSEcCtD
Olmesartan—Body temperature increased—Docetaxel—melanoma	0.000365	0.00123	CcSEcCtD
Olmesartan—Asthenia—Docetaxel—melanoma	0.000331	0.00112	CcSEcCtD
Olmesartan—Pruritus—Docetaxel—melanoma	0.000327	0.0011	CcSEcCtD
Olmesartan—Diarrhoea—Docetaxel—melanoma	0.000316	0.00106	CcSEcCtD
Olmesartan—Dizziness—Docetaxel—melanoma	0.000305	0.00103	CcSEcCtD
Olmesartan—Vomiting—Docetaxel—melanoma	0.000294	0.000989	CcSEcCtD
Olmesartan—Rash—Docetaxel—melanoma	0.000291	0.00098	CcSEcCtD
Olmesartan—Dermatitis—Docetaxel—melanoma	0.000291	0.000979	CcSEcCtD
Olmesartan—Headache—Docetaxel—melanoma	0.000289	0.000974	CcSEcCtD
Olmesartan—Nausea—Docetaxel—melanoma	0.000274	0.000924	CcSEcCtD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000198	0.0011	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL1—melanoma	0.000194	0.00107	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PLCB4—melanoma	0.000194	0.00107	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—UGT2B10—melanoma	0.000193	0.00107	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.00019	0.00105	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC6A11—melanoma	0.00019	0.00105	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIP4K2A—melanoma	0.00019	0.00105	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCR2—melanoma	0.000188	0.00104	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000186	0.00103	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—RAC2—melanoma	0.000185	0.00102	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—MTAP—melanoma	0.000185	0.00102	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—WNT5A—melanoma	0.000182	0.00101	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TRRAP—melanoma	0.000182	0.00101	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CUL3—melanoma	0.000182	0.00101	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000181	0.000999	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HS3ST5—melanoma	0.000179	0.000991	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKR1B10—melanoma	0.000177	0.00098	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—F2R—melanoma	0.000176	0.000975	CbGpPWpGaD
Olmesartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—melanoma	0.000174	0.000963	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—EDNRB—melanoma	0.000171	0.000944	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—LUM—melanoma	0.000165	0.000911	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PHGDH—melanoma	0.000165	0.000911	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—F2RL1—melanoma	0.000165	0.000911	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—HPSE—melanoma	0.000162	0.000893	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—GNA11—melanoma	0.000161	0.000892	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—GAB2—melanoma	0.000161	0.000892	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—F2R—melanoma	0.00016	0.000885	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CUBN—melanoma	0.000159	0.000877	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—melanoma	0.000158	0.000875	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EDNRB—melanoma	0.000155	0.000857	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GRM3—melanoma	0.000155	0.000856	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SDHD—melanoma	0.000153	0.000847	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—BSG—melanoma	0.000153	0.000847	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CSPG4—melanoma	0.000153	0.000847	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCR4—melanoma	0.000152	0.000838	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—melanoma	0.000151	0.000838	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—GNAQ—melanoma	0.00015	0.000829	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GPAM—melanoma	0.000148	0.00082	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KISS1—melanoma	0.000147	0.000812	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—GNA11—melanoma	0.000146	0.00081	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—GAB2—melanoma	0.000146	0.00081	CbGpPWpGaD
Olmesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—melanoma	0.000146	0.000807	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000144	0.000797	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—melanoma	0.000144	0.000797	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—melanoma	0.000144	0.000797	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SKI—melanoma	0.000142	0.000786	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCR1—melanoma	0.000142	0.000786	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ABCB1—melanoma	0.000141	0.000782	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MC1R—melanoma	0.00014	0.000774	CbGpPWpGaD
Olmesartan—AGTR1—G alpha (q) signalling events—PIK3CA—melanoma	0.00014	0.000773	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT3—melanoma	0.000138	0.000765	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCR4—melanoma	0.000138	0.000761	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—GNAQ—melanoma	0.000136	0.000753	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—melanoma	0.000136	0.000753	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLCB4—melanoma	0.000136	0.000751	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GRM1—melanoma	0.000134	0.000742	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCR7—melanoma	0.000134	0.000742	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000133	0.000737	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000133	0.000734	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SUFU—melanoma	0.000131	0.000723	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC6A11—melanoma	0.000128	0.000706	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIP4K2A—melanoma	0.000128	0.000706	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PLA2G6—melanoma	0.000126	0.000697	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT3—melanoma	0.000126	0.000695	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—melanoma	0.000125	0.000692	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—melanoma	0.000125	0.000689	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—MTAP—melanoma	0.000124	0.000687	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BCL2L11—melanoma	0.000122	0.000675	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RHOB—melanoma	0.000122	0.000675	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000121	0.000671	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HDAC6—melanoma	0.000117	0.000649	CbGpPWpGaD
Olmesartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—melanoma	0.000117	0.000647	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—EDN1—melanoma	0.000116	0.000643	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—melanoma	0.000116	0.00064	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CSF2—melanoma	0.000114	0.000628	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—VCAN—melanoma	0.000113	0.000627	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCR2—melanoma	0.000111	0.000615	CbGpPWpGaD
Olmesartan—AGTR1—GPCR ligand binding—CXCL8—melanoma	0.000111	0.000615	CbGpPWpGaD
Olmesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—melanoma	0.000111	0.000612	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PHGDH—melanoma	0.000111	0.000612	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—LUM—melanoma	0.000111	0.000612	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RAC2—melanoma	0.000109	0.000605	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PRKCA—melanoma	0.000109	0.000602	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—HPSE—melanoma	0.000109	0.0006	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFC—melanoma	0.000108	0.000596	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—WNT5A—melanoma	0.000108	0.000596	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000107	0.000593	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CUBN—melanoma	0.000107	0.000589	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EDN1—melanoma	0.000106	0.000584	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000104	0.000572	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CSF2—melanoma	0.000103	0.000571	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SDHD—melanoma	0.000103	0.000569	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—BSG—melanoma	0.000103	0.000569	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CSPG4—melanoma	0.000103	0.000569	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ABCB1—melanoma	0.000101	0.00056	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—RAC1—melanoma	0.000101	0.000558	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GPAM—melanoma	9.97e-05	0.000551	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PRKCA—melanoma	9.89e-05	0.000547	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MAP2K2—melanoma	9.67e-05	0.000535	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP17A1—melanoma	9.56e-05	0.000529	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—melanoma	9.5e-05	0.000526	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—F2R—melanoma	9.46e-05	0.000523	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	9.43e-05	0.000521	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—melanoma	9.31e-05	0.000515	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—RAC1—melanoma	9.17e-05	0.000507	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDNRB—melanoma	9.16e-05	0.000507	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GNA11—melanoma	9.03e-05	0.000499	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTK2B—melanoma	8.89e-05	0.000492	CbGpPWpGaD
Olmesartan—SLCO1B3—Transmembrane transport of small molecules—ALB—melanoma	8.85e-05	0.000489	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—FASN—melanoma	8.83e-05	0.000489	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—SLC5A5—melanoma	8.69e-05	0.000481	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GAB2—melanoma	8.65e-05	0.000478	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GNA11—melanoma	8.65e-05	0.000478	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FLT1—melanoma	8.61e-05	0.000476	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CG—melanoma	8.53e-05	0.000472	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PLA2G6—melanoma	8.47e-05	0.000469	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—GNAQ—melanoma	8.39e-05	0.000464	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CD44—melanoma	8.39e-05	0.000464	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.22e-05	0.000454	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.14e-05	0.00045	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FOXO4—melanoma	8.13e-05	0.00045	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HDAC2—melanoma	8.13e-05	0.00045	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCR4—melanoma	8.13e-05	0.00045	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—CYP1B1—melanoma	8.05e-05	0.000445	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—GNAQ—melanoma	8.04e-05	0.000445	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CG—melanoma	7.75e-05	0.000428	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—VCAN—melanoma	7.61e-05	0.000421	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SYK—melanoma	7.56e-05	0.000418	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CD—melanoma	7.5e-05	0.000415	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NGFR—melanoma	7.42e-05	0.00041	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT3—melanoma	7.42e-05	0.00041	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ITGAV—melanoma	7.42e-05	0.00041	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.21e-05	0.000398	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.1e-05	0.000393	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.95e-05	0.000385	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SOCS1—melanoma	6.87e-05	0.00038	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MAP2K1—melanoma	6.86e-05	0.000379	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—S100B—melanoma	6.86e-05	0.000379	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CD—melanoma	6.81e-05	0.000377	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ABCB1—melanoma	6.63e-05	0.000366	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ERBB4—melanoma	6.56e-05	0.000363	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CB—melanoma	6.54e-05	0.000362	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN2B—melanoma	6.5e-05	0.000359	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP17A1—melanoma	6.42e-05	0.000355	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.33e-05	0.00035	CbGpPWpGaD
Olmesartan—ABCC2—Transmembrane transport of small molecules—ALB—melanoma	6.33e-05	0.00035	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CD86—melanoma	6.29e-05	0.000348	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—CXCL8—melanoma	6.28e-05	0.000347	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—melanoma	6.25e-05	0.000346	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EDN1—melanoma	6.24e-05	0.000345	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PRKCA—melanoma	6.1e-05	0.000337	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CSF2—melanoma	6.09e-05	0.000337	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF1—melanoma	6.09e-05	0.000337	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GNA11—melanoma	6.07e-05	0.000335	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ERCC2—melanoma	6.05e-05	0.000334	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—IL2—melanoma	6e-05	0.000332	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—E2F1—melanoma	5.96e-05	0.00033	CbGpPWpGaD
Olmesartan—SLCO1B1—Transmembrane transport of small molecules—ALB—melanoma	5.95e-05	0.000329	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CB—melanoma	5.94e-05	0.000328	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—FASN—melanoma	5.94e-05	0.000328	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PDGFRA—melanoma	5.9e-05	0.000326	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ITGB3—melanoma	5.84e-05	0.000323	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PRKCA—melanoma	5.84e-05	0.000323	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—SLC5A5—melanoma	5.84e-05	0.000323	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—SPP1—melanoma	5.73e-05	0.000317	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAP2K2—melanoma	5.71e-05	0.000316	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—CXCL8—melanoma	5.71e-05	0.000315	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—GNAQ—melanoma	5.64e-05	0.000312	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CD44—melanoma	5.64e-05	0.000312	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.52e-05	0.000305	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.47e-05	0.000303	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL2—melanoma	5.45e-05	0.000301	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TERT—melanoma	5.43e-05	0.0003	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—RAC1—melanoma	5.42e-05	0.0003	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—CYP1B1—melanoma	5.41e-05	0.000299	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HIF1A—melanoma	5.2e-05	0.000287	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.01e-05	0.000277	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KDR—melanoma	4.97e-05	0.000275	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FN1—melanoma	4.78e-05	0.000264	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CG—melanoma	4.78e-05	0.000264	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.77e-05	0.000264	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NOTCH1—melanoma	4.68e-05	0.000259	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PPARG—melanoma	4.61e-05	0.000255	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CD80—melanoma	4.59e-05	0.000254	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—APC—melanoma	4.58e-05	0.000253	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CG—melanoma	4.58e-05	0.000253	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KIT—melanoma	4.58e-05	0.000253	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—NRAS—melanoma	4.58e-05	0.000253	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGF—melanoma	4.52e-05	0.00025	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ABCB1—melanoma	4.45e-05	0.000246	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MAPK3—melanoma	4.38e-05	0.000242	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—BRAF—melanoma	4.3e-05	0.000238	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CD—melanoma	4.2e-05	0.000232	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IGF1—melanoma	4.19e-05	0.000232	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—MAPK1—melanoma	4.17e-05	0.000231	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—EGFR—melanoma	4.17e-05	0.000231	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—ALB—melanoma	4.14e-05	0.000229	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PRKCA—melanoma	4.1e-05	0.000227	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ERCC2—melanoma	4.06e-05	0.000225	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAP2K1—melanoma	4.05e-05	0.000224	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CD—melanoma	4.02e-05	0.000222	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—PIK3CA—melanoma	3.99e-05	0.00022	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—KRAS—melanoma	3.94e-05	0.000218	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—FGF2—melanoma	3.85e-05	0.000213	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CB—melanoma	3.66e-05	0.000202	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTGS2—melanoma	3.63e-05	0.000201	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—PIK3CA—melanoma	3.62e-05	0.0002	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MDM2—melanoma	3.6e-05	0.000199	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—ERBB2—melanoma	3.55e-05	0.000197	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CB—melanoma	3.51e-05	0.000194	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CXCL8—melanoma	3.37e-05	0.000186	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.37e-05	0.000186	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—HRAS—melanoma	3.35e-05	0.000185	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN1B—melanoma	3.29e-05	0.000182	CbGpPWpGaD
Olmesartan—AGTR1—GPCR downstream signaling—AKT1—melanoma	3.26e-05	0.00018	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CASP3—melanoma	3.23e-05	0.000178	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL2—melanoma	3.22e-05	0.000178	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CG—melanoma	3.21e-05	0.000177	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—IL6—melanoma	3.2e-05	0.000177	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PTEN—melanoma	3.16e-05	0.000175	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CCND1—melanoma	3.14e-05	0.000174	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CTNNB1—melanoma	3.11e-05	0.000172	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PPARG—melanoma	3.1e-05	0.000171	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MMP9—melanoma	3.05e-05	0.000169	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—CDKN1A—melanoma	3.04e-05	0.000168	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PTEN—melanoma	3.03e-05	0.000168	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NFKB1—melanoma	3.02e-05	0.000167	CbGpPWpGaD
Olmesartan—AGTR1—Signaling by GPCR—AKT1—melanoma	2.96e-05	0.000163	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CD—melanoma	2.82e-05	0.000156	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—ALB—melanoma	2.78e-05	0.000154	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—VEGFA—melanoma	2.74e-05	0.000151	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—STAT3—melanoma	2.71e-05	0.00015	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—NRAS—melanoma	2.7e-05	0.00015	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK3—melanoma	2.59e-05	0.000143	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MYC—melanoma	2.52e-05	0.000139	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—MAPK1—melanoma	2.46e-05	0.000136	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—EGFR—melanoma	2.46e-05	0.000136	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CB—melanoma	2.46e-05	0.000136	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTGS2—melanoma	2.44e-05	0.000135	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—KRAS—melanoma	2.33e-05	0.000129	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—PIK3CA—melanoma	2.23e-05	0.000123	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—PIK3CA—melanoma	2.14e-05	0.000118	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PTEN—melanoma	2.12e-05	0.000117	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—TP53—melanoma	2.07e-05	0.000114	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—HRAS—melanoma	1.98e-05	0.000109	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—IL6—melanoma	1.89e-05	0.000105	CbGpPWpGaD
Olmesartan—SLCO1B3—Metabolism—AKT1—melanoma	1.82e-05	0.000101	CbGpPWpGaD
Olmesartan—AGTR1—Signaling Pathways—AKT1—melanoma	1.75e-05	9.66e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—PIK3CA—melanoma	1.5e-05	8.29e-05	CbGpPWpGaD
Olmesartan—SLCO1B1—Metabolism—AKT1—melanoma	1.22e-05	6.77e-05	CbGpPWpGaD
